(Photo by: Plexi Images/GHI/UCG/Universal Images Group via ... an mRNA bird flu shot also rose on news of the bird flu death. Novavax stock (NVAX) surged nearly 11% Tuesday. German biotech firm ...

Moderna MRNA announced that the U.S. government, through the Biomedical Advanced Research and Development Authority (“BARDA”), has awarded the company $590 million to accelerate the development of an ...

Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...

I have been warning about Novavax's risks since 2016, highlighting its ongoing struggles with the FDA. Novavax's Q3 2024 earnings call and 10-Q reveal a collaboration negotiated from a position of ...

The most recent trading session ended with Novavax (NVAX) standing at $9.34, reflecting a +1.3% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily loss of 1.46%.

Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC report on rising respiratory illnesses. Get Wall Street's Hottest ...

Novavax shares are trading higher by 13.5% during Tuesday's session. A recent CDC report highlights a sharp increase in respiratory illnesses across the United States. Get Wall Street's Hottest ...

Novavax continues to progress Sanofi agreement by achieving first milestone, with additional milestones and ongoing tiered royalties to come, solidifying a strong model for future partnerships Novavax ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...